L3VLUP
← Every manager
Free · no sign-up · Q2 2026

Which funds own BCRX

Biocryst Pharmaceuticals Inc in the Q2 2026 filings. At least 1 of the 91 current managers on file reported a position, worth $8.5m between them. It is among the largest positions of fewer than a fifth of the current managers on file. Buying and selling roughly cancelled this quarter, which is what a name looks like when the argument is still live.

Managers holding
1
at least, of 91 current
Combined value
$8.5m
as reported
Opened
1
new this quarter
Added to
0
already held
Trimmed or sold out
1
1 sold out entirely

Only each manager’s largest 200 positions are listed here, so a smaller holder may be missing.

Managers reporting a position

Largest first. Weight is the share of that manager’s whole reported book, which is the number worth quoting: $400m is a rounding error in one book and a defining bet in another.

ManagerValueWeightSharesChange on the quarterAction
Moore Capital Management LP
Macro · $6.7bn book
$8.5m0.1%848,336opened848,336New

Sold out of this quarter

Valued at what the position was worth in the previous filing, because by this one it is gone.

Ownership through time

At least 7 of the 95 managers whose filings are on file listed BCRX in Q2 2026, against 1 in Q4 2013. 1 manager more than in Q1 2026: 1 started a position; 2 listed it again; 1 sold out, by its own filing; 1 no longer listed it among the positions read, which can mean a holding below the listed range, a filing that reported no holdings, or a filing not yet made.

Each manager’s largest 500 positions a quarter are read, so a small holding in a very large book can be missing, and a manager is counted as leaving only where its own filing shows it.

Managers on file listing it
048Q4 2013: 1Q1 2014: 114Q2 2014: 2Q2 2015: 3Q3 2015: 2Q3 2016: 1Q4 2016: 1Q1 2017: 317Q2 2017: 1Q1 2018: 118Q2 2018: 1Q3 2018: 2Q4 2018: 1Q1 2019: 119Q2 2019: 1Q3 2019: 3Q4 2019: 3Q1 2020: 420Q2 2020: 4Q3 2020: 2Q4 2020: 3Q1 2021: 121Q2 2021: 3Q3 2021: 6Q4 2021: 4Q1 2022: 522Q2 2022: 4Q3 2022: 7Q4 2022: 8Q1 2023: 623Q2 2023: 4Q3 2023: 4Q4 2023: 2Q1 2024: 324Q2 2024: 3Q3 2024: 3Q4 2024: 2Q1 2025: 425Q2 2025: 7Q3 2025: 5Q4 2025: 6Q1 2026: 626Q2 2026: 7
  • Q4 2013: 1
  • Q1 2014: 1
  • Q2 2014: 2
  • Q2 2015: 3
  • Q3 2015: 2
  • Q3 2016: 1
  • Q4 2016: 1
  • Q1 2017: 3
  • Q2 2017: 1
  • Q1 2018: 1
  • Q2 2018: 1
  • Q3 2018: 2
  • Q4 2018: 1
  • Q1 2019: 1
  • Q2 2019: 1
  • Q3 2019: 3
  • Q4 2019: 3
  • Q1 2020: 4
  • Q2 2020: 4
  • Q3 2020: 2
  • Q4 2020: 3
  • Q1 2021: 1
  • Q2 2021: 3
  • Q3 2021: 6
  • Q4 2021: 4
  • Q1 2022: 5
  • Q2 2022: 4
  • Q3 2022: 7
  • Q4 2022: 8
  • Q1 2023: 6
  • Q2 2023: 4
  • Q3 2023: 4
  • Q4 2023: 2
  • Q1 2024: 3
  • Q2 2024: 3
  • Q3 2024: 3
  • Q4 2024: 2
  • Q1 2025: 4
  • Q2 2025: 7
  • Q3 2025: 5
  • Q4 2025: 6
  • Q1 2026: 6
  • Q2 2026: 7
Their combined reported value
$0$93m$187mQ4 2013: $692kQ1 2014: $632k14Q2 2014: $34mQ2 2015: $165mQ3 2015: $114mQ3 2016: $714kQ4 2016: $828kQ1 2017: $28m17Q2 2017: $718kQ1 2018: $2.7m18Q2 2018: $64mQ3 2018: $95mQ4 2018: $99mQ1 2019: $100m19Q2 2019: $8.5mQ3 2019: $20mQ4 2019: $39mQ1 2020: $15m20Q2 2020: $53mQ3 2020: $4.8mQ4 2020: $33mQ1 2021: $31m21Q2 2021: $88mQ3 2021: $119mQ4 2021: $79mQ1 2022: $83m22Q2 2022: $60mQ3 2022: $85mQ4 2022: $111mQ1 2023: $59m23Q2 2023: $53mQ3 2023: $44mQ4 2023: $15mQ1 2024: $16m24Q2 2024: $30mQ3 2024: $34mQ4 2024: $23mQ1 2025: $50m25Q2 2025: $170mQ3 2025: $74mQ4 2025: $138mQ1 2026: $170m26Q2 2026: $187m
  • Q4 2013: $692k
  • Q1 2014: $632k
  • Q2 2014: $34m
  • Q2 2015: $165m
  • Q3 2015: $114m
  • Q3 2016: $714k
  • Q4 2016: $828k
  • Q1 2017: $28m
  • Q2 2017: $718k
  • Q1 2018: $2.7m
  • Q2 2018: $64m
  • Q3 2018: $95m
  • Q4 2018: $99m
  • Q1 2019: $100m
  • Q2 2019: $8.5m
  • Q3 2019: $20m
  • Q4 2019: $39m
  • Q1 2020: $15m
  • Q2 2020: $53m
  • Q3 2020: $4.8m
  • Q4 2020: $33m
  • Q1 2021: $31m
  • Q2 2021: $88m
  • Q3 2021: $119m
  • Q4 2021: $79m
  • Q1 2022: $83m
  • Q2 2022: $60m
  • Q3 2022: $85m
  • Q4 2022: $111m
  • Q1 2023: $59m
  • Q2 2023: $53m
  • Q3 2023: $44m
  • Q4 2023: $15m
  • Q1 2024: $16m
  • Q2 2024: $30m
  • Q3 2024: $34m
  • Q4 2024: $23m
  • Q1 2025: $50m
  • Q2 2025: $170m
  • Q3 2025: $74m
  • Q4 2025: $138m
  • Q1 2026: $170m
  • Q2 2026: $187m

Between the quarter ends of Q1 2026 and Q2 2026. Each change in shares is valued at the Q2 2026 price, so the price’s own move is left out; a 13F shows the two quarter ends, not when in between anything was bought or sold.

Started in Q2 2026

Largest increases, by shares

Largest decreases, by shares

ManagerValue over timeFirst listedLargestQ2 2026
Janus Henderson Group LtdQ2 2018$100m$95m
Two Sigma Investments LPQ2 2020$68m$68m
Moore Capital Management LPQ4 2022$8.5m$8.5m
ExodusPoint Capital Management LPQ2 2022$10m$7.4m
Bridgewater Associates LPQ1 2026$6.1m$4.9m
Winton Group LtdQ2 2026$2.6m$2.6m
PDT Partners LLCQ4 2013$6.1m$245k
Wellington Management Group LLPQ2 2015$104mlast listed Q3 2015
Artisan Partners LPQ1 2021$50mlast listed Q1 2023
Arrowstreet Capital LPQ2 2025$38mlast listed Q2 2025
Two Sigma Advisers LPQ3 2021$38mlast listed Q4 2025
D. E. Shaw & Co.Q2 2014$32mlast listed Q1 2017
Millennium Management LLCQ2 2015$31mlast listed Q2 2020
Point72 Asset Management LPQ3 2019$29mlast listed Q3 2023
Woodline Partners LPQ4 2019$24mlast listed Q1 2023
Voloridge Investment Management LLCQ4 2020$22mlast listed Q2 2025
Walleye Capital LLCQ1 2020$21mlast listed Q2 2025

What BCRX is worth

Knowing who owns it is half the question. The other half is what it is worth against the companies it trades beside, which is the one an interviewer will follow up with.

Build the comp set around BCRX →

How much of the picture this is

A Form 13F reports US-listed long equity and nothing else: no shorts, no bonds, no cash and no non-US listings. It arrives forty-five days after the quarter ends, so a manager who sold in July still shows the position in a filing published in August. This page reads the managers on file here rather than every filer in the market, and each manager’s largest positions rather than the whole table, so a small position in a very large book may not appear. Say “their last filing showed” rather than “they own”, and the distinction will do you credit.

What to do with a name the funds are buying

Knowing who owns something is the start of a pitch, not the pitch. The next questions are what it is worth and why they were buying.

Company names, tickers and logos are the trademarks of their respective owners and appear here to identify the company whose public figures are being used. L3VLUP is not affiliated with, sponsored by or endorsed by any company shown, and nothing here is a statement by or about that company. More

The holdings, every quarter, and the week between

One email a week on what moved in the market and what it means for the people interviewing into it, with the 13F changes the quarter they are filed.

One email a week, free, and you can leave at any point.